GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM4093
Query DataSets for GSM4093
Status
Public on Feb 22, 2003
Title
PGA-MGC-ctr6-1aAv2-s2
Sample type
RNA
Source name
Murine Lung
Organism
Mus musculus
Extracted molecule
total RNA
Description
A-J mice were treated intratracheally with saline solution to monitor the production of goblet cells that are thought to increase mucus in airways- a characteristic phenotype in the airways of human asthma and murine models of allergic asthma.
Submission date
Feb 20, 2003
Last update date
Oct 01, 2019
Contact name
Eric P Hoffman
E-mail(s)
[email protected]
Organization name
Binghamton University - SUNY
Department
Pharmaceutical Sciences
Street address
PO Box 6000
City
Binghamton
State/province
NY
ZIP/Postal code
13902
Country
USA
Platform ID
GPL81
Series (1)
GSE481
Allergen-induced goblet cells
Data table header descriptions
ID_REF
VALUE
Average Difference Intensity (See Affymetrix Literature)
ABS_CALL
Presence or Absence of gene transcript in sample
Data table
ID_REF
VALUE
ABS_CALL
AFFX-MurIL2_at
22.023939
A
AFFX-MurIL10_at
20.196815
A
AFFX-MurIL4_at
9.16465
A
AFFX-MurFAS_at
179.920807
M
AFFX-BioB-5_at
483.301208
P
AFFX-BioB-M_at
1071.889282
P
AFFX-BioB-3_at
315.518036
P
AFFX-BioC-5_at
1561.585938
P
AFFX-BioC-3_at
1305.962769
P
AFFX-BioDn-5_at
1161.21814
P
AFFX-BioDn-3_at
8231.486328
P
AFFX-CreX-5_at
13074.629883
P
AFFX-CreX-3_at
21279.314453
P
AFFX-DapX-5_at
53.019722
A
AFFX-DapX-M_at
56.135246
A
AFFX-DapX-3_at
11.406181
A
AFFX-LysX-5_at
4.447292
A
AFFX-LysX-M_at
19.459988
A
AFFX-LysX-3_at
24.938377
A
AFFX-PheX-5_at
4.465742
A
Total number of rows:
12488
Table truncated, full table size
278 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM4093.CEL.gz
3.2 Mb
(ftp)
(http)
CEL
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
